首页 > 最新文献

Archives De Pediatrie最新文献

英文 中文
Franco-African paediatric teledermatology: a store-and-forward network 法非儿科远程皮肤病学:储存和转发网络。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.09.007
Asmaa Lahrougui , Dalila Benlahcene , Saïd Afif , Emmanuel Mahé

Background

Given the frequency of dermatological diseases in children and the difficulties in accessing specialist care in Africa, teledermatology services, such as store-and-forward (SAF), could be used an alternative approach for improving patient care. The dermatology department of the Argenteuil hospital in France developed a SAF network with paediatricians from seven French-speaking African countries. This study assessed the value of this Franco-African SAF collaboration by identifying the advantages and challenges associated with the first 100 uses of the SAF system.

Methods

Paediatricians belonging to medical societies in French-speaking African countries were provided with information on how to register for the SAF service. The first 100 SAF requests were evaluated. Information about the paediatricians who used the service, and patient demographic, clinical and management data were systematically collected.

Results

Twenty-five (10.2%) paediatricians, out of 244 who registered, submitted cases to the SAF network. In 95 cases, a response was sent within 24 h of submission. In 24 cases, additional information was needed (clinical data, n = 17; photos, n = 6; a histological report, n = 1; identity details, n = 1). The mean age of the children was 5.8 ± 5.0 years, with a predominance of girls (n = 61). Most patients had chronic pathologies (≥ 1 month) (n = 56) belonging to three main groups: chronic inflammatory diseases (n = 42), infectious diseases (n = 23), and genetic diseases (n = 11). As a result of the SAF requests, further examinations were proposed in 39 cases, treatment in 82 cases, and hospitalisation in 11 cases.

Conclusion

The SAF approach is an effective solution for improving access to dermatological care in Africa, providing an alternative method for expert consultation when resources are limited, without diminishing the role of local dermatologists. For dermatologists, this solution provides access to expertise on unusual pathologies and allows solutions to be offered that are tailored to the resources available in the field.
背景:考虑到非洲儿童皮肤病的发病率和获得专科护理的困难,远程皮肤科服务,如储存转发(SAF),可作为改善患者护理的另一种方法。法国阿让特伊医院的皮肤科与七个讲法语的非洲国家的儿科医生建立了一个SAF网络。本研究通过确定与SAF系统的前100次使用相关的优势和挑战,评估了法国-非洲SAF合作的价值。方法:向非洲法语国家医学协会的儿科医生提供如何注册SAF服务的信息。评估了前100个SAF请求。系统地收集了使用该服务的儿科医生的信息以及患者人口统计、临床和管理数据。结果:244名注册的儿科医生中,有25名(10.2%)向SAF网络提交了病例。在95个案件中,在提交后24小时内发出了答复。24例需要补充资料(临床资料17例;照片6例;组织学报告1例;身份信息1例)。患儿平均年龄5.8±5.0岁,以女童为主(n = 61)。大多数患者有慢性病变(≥1个月)(n = 56),主要分为三大类:慢性炎症性疾病(n = 42)、感染性疾病(n = 23)和遗传性疾病(n = 11)。根据安全部队的要求,对39例进行了进一步检查,82例进行了治疗,11例住院治疗。结论:SAF方法是改善非洲皮肤科护理可及性的有效解决方案,在资源有限的情况下为专家咨询提供了另一种方法,而不会削弱当地皮肤科医生的作用。对于皮肤科医生来说,该解决方案提供了对异常病理的专业知识的访问,并允许根据该领域的可用资源提供量身定制的解决方案。
{"title":"Franco-African paediatric teledermatology: a store-and-forward network","authors":"Asmaa Lahrougui ,&nbsp;Dalila Benlahcene ,&nbsp;Saïd Afif ,&nbsp;Emmanuel Mahé","doi":"10.1016/j.arcped.2025.09.007","DOIUrl":"10.1016/j.arcped.2025.09.007","url":null,"abstract":"<div><h3>Background</h3><div>Given the frequency of dermatological diseases in children and the difficulties in accessing specialist care in Africa, teledermatology services, such as store-and-forward (SAF), could be used an alternative approach for improving patient care. The dermatology department of the Argenteuil hospital in France developed a SAF network with paediatricians from seven French-speaking African countries. This study assessed the value of this Franco-African SAF collaboration by identifying the advantages and challenges associated with the first 100 uses of the SAF system.</div></div><div><h3>Methods</h3><div>Paediatricians belonging to medical societies in French-speaking African countries were provided with information on how to register for the SAF service. The first 100 SAF requests were evaluated. Information about the paediatricians who used the service, and patient demographic, clinical and management data were systematically collected.</div></div><div><h3>Results</h3><div>Twenty-five (10.2%) paediatricians, out of 244 who registered, submitted cases to the SAF network. In 95 cases, a response was sent within 24 h of submission. In 24 cases, additional information was needed (clinical data, <em>n</em> = 17; photos, <em>n</em> = 6; a histological report, <em>n</em> = 1; identity details, <em>n</em> = 1). The mean age of the children was 5.8 ± 5.0 years, with a predominance of girls (<em>n</em> = 61). Most patients had chronic pathologies (≥ 1 month) (<em>n</em> = 56) belonging to three main groups: chronic inflammatory diseases (<em>n</em> = 42), infectious diseases (<em>n</em> = 23), and genetic diseases (<em>n</em> = 11). As a result of the SAF requests, further examinations were proposed in 39 cases, treatment in 82 cases, and hospitalisation in 11 cases.</div></div><div><h3>Conclusion</h3><div>The SAF approach is an effective solution for improving access to dermatological care in Africa, providing an alternative method for expert consultation when resources are limited, without diminishing the role of local dermatologists. For dermatologists, this solution provides access to expertise on unusual pathologies and allows solutions to be offered that are tailored to the resources available in the field.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 592-598"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145454299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of permanent parental presence and its determinants in a French neonatal intensive care unit practicing couplet care 评估永久父母存在及其决定因素在法国新生儿重症监护病房实行对联护理。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.07.007
Sylvaine Rousseau , Lorna Ramelin , Patrick Truffert , Cerise Levaillant
Couplet Care ensures zero separation between mother and baby from birth, fostering attachment, particularly for hospitalized premature or full-term infants. Implementation of mother-child paired care was initiated in 2017 at our center. This study aimed to quantify parental presence during hospitalization and identify its determinants.

Method

This retrospective study analyzed data from September to December 2023, recorded by healthcare staff. We included in the study preterm and full-term infants admitted to our level II neonatal unit during this period. Parental involvement was confirmed by at least one of three factors between 0 and 6 am: breastfeeding, parental care, or skin-to-skin contact. Continuous parental presence was defined as 100 % of nights with parental involvement.

Results

Of the 110 children admitted during this period, 37 were excluded, primarily due to admission from home. Among 73 included newborns, 46 (63 %) had parental presence every night. These infants (Permanent Parental Presence—PPP group) had a higher mean gestational age at birth than those with Discontinuous Parental Presence (DPP) (36.3 vs. 31.3 weeks, p < 0.0001). More PPP infants were inborn (80.4 % vs. 51.9 %, p = 0.01). Their hospital stay was shorter (15.9 vs. 45.6 days, p < 0.0001). Breastfeeding rate at admission and at discharge was significantly higher in the PPP group (respectively 91 % vs 74 %, p = 0.05 and 84.7 % vs. 51.8 %, p = 0.002). Distance between home and the neonatal unit was smaller in the PPP group (6.5 km vs 8.8 km, p = 0.03). Multiparity showed no impact on parental presence.

Conclusion

Couplet Care and single-room accommodations encourage continuous parental presence in neonatology. Different ways to support parents’ continuous presence in order to promote parent-child closeness should be promoted.
对联护理确保母亲和婴儿从出生时零分离,培养依恋,特别是对住院的早产儿或足月婴儿。我中心于2017年开始实施母婴配对照护。本研究旨在量化住院期间父母的存在并确定其决定因素。方法:回顾性分析2023年9 - 12月卫生保健人员记录的资料。我们在研究中纳入了在此期间入住我们二级新生儿病房的早产儿和足月婴儿。在早上0点到6点之间,父母的参与至少可以通过以下三个因素中的一个来证实:母乳喂养、父母的照顾或皮肤接触。持续的父母陪伴被定义为100%有父母参与的夜晚。结果:在此期间入院的110名儿童中,37名被排除在外,主要原因是在家入院。在纳入的73名新生儿中,有46名(63%)每晚有父母在场。这些婴儿(父母永久存在- ppp组)出生时的平均胎龄高于父母间断存在(DPP)组(36.3周对31.3周,p < 0.0001)。PPP新生儿较多(80.4%比51.9%,p = 0.01)。住院时间较短(15.9天对45.6天,p < 0.0001)。PPP组入院和出院时母乳喂养率分别为91%比74% (p = 0.05)和84.7%比51.8% (p = 0.002)。PPP组家庭与新生儿单位之间的距离更小(6.5公里vs 8.8公里,p = 0.03)。多胎对亲本存在没有影响。结论:对联护理和单间住宿鼓励父母在新生儿中持续存在。应该提倡不同的方式来支持父母的持续存在,以促进亲子亲密关系。
{"title":"Evaluation of permanent parental presence and its determinants in a French neonatal intensive care unit practicing couplet care","authors":"Sylvaine Rousseau ,&nbsp;Lorna Ramelin ,&nbsp;Patrick Truffert ,&nbsp;Cerise Levaillant","doi":"10.1016/j.arcped.2025.07.007","DOIUrl":"10.1016/j.arcped.2025.07.007","url":null,"abstract":"<div><div>Couplet Care ensures zero separation between mother and baby from birth, fostering attachment, particularly for hospitalized premature or full-term infants. Implementation of mother-child paired care was initiated in 2017 at our center. This study aimed to quantify parental presence during hospitalization and identify its determinants.</div></div><div><h3>Method</h3><div>This retrospective study analyzed data from September to December 2023, recorded by healthcare staff. We included in the study preterm and full-term infants admitted to our level II neonatal unit during this period. Parental involvement was confirmed by at least one of three factors between 0 and 6 am: breastfeeding, parental care, or skin-to-skin contact. Continuous parental presence was defined as 100 % of nights with parental involvement.</div></div><div><h3>Results</h3><div>Of the 110 children admitted during this period, 37 were excluded, primarily due to admission from home. Among 73 included newborns, 46 (63 %) had parental presence every night. These infants (Permanent Parental Presence—PPP group) had a higher mean gestational age at birth than those with Discontinuous Parental Presence (DPP) (36.3 vs. 31.3 weeks, <em>p</em> &lt; 0.0001). More PPP infants were inborn (80.4 % vs. 51.9 %, <em>p</em> = 0.01). Their hospital stay was shorter (15.9 vs. 45.6 days, <em>p</em> &lt; 0.0001). Breastfeeding rate at admission and at discharge was significantly higher in the PPP group (respectively 91 % vs 74 %, <em>p</em> = 0.05 and 84.7 % vs. 51.8 %, <em>p</em> = 0.002). Distance between home and the neonatal unit was smaller in the PPP group (6.5 km vs 8.8 km, <em>p</em> = 0.03). Multiparity showed no impact on parental presence.</div></div><div><h3>Conclusion</h3><div>Couplet Care and single-room accommodations encourage continuous parental presence in neonatology. Different ways to support parents’ continuous presence in order to promote parent-child closeness should be promoted.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 558-563"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy 在高效调节疗法时代,为囊性纤维化患者开发一种新的治疗模式的干预制图。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.08.001
Julie Haesebaert , Quitterie Reynaud , Isabelle Durieu , Stephanie Poupon-Bourdy , Thierry Nouvel , Philippe Reix , the Horizon CF center’s investigators
Highly effective modulator therapy (HEMT) is available to a broader range of people with cystic fibrosis (pwCF). It has significantly improved short-term clinical outcomes and has the potential to alter the natural history of this fatal genetic disease. If long-term follow-up observational data is required to ensure clinical benefits, it is obvious that it will also change the needs of pwCF and the roles and missions of healthcare professionals (HCPs) in CF centers and beyond. We will conduct a nationwide research program called 'HORIZON' to support the changes in the organization of CF care in the coming years. It has received the financial support of the French Ministry of Health in 2022. Our primary objective is to design a new model of care that respond to the new needs and missions of pwCF and HCPs in this era of rapid and profound changes due to HEMT. This research program is based on the intervention mapping method, in which we will conduct the first four steps to design and plan the implementation of a new model of care. The program will involve all stakeholders of the CF care network, including HCPs from CF care centers and outside, pwCF, their families, patient organizations, and experts in CF. It will combine quantitative and qualitative research approaches and rely on an 'action research' method. Anticipating and supporting the reorganization of CF care in France requires a robust research program to find the best model that meets the expectations of all key stakeholders.
高效调节疗法(HEMT)可用于更广泛的囊性纤维化(pwCF)患者。它显著改善了短期临床结果,并有可能改变这种致命遗传疾病的自然史。如果需要长期随访观察数据来确保临床获益,那么很明显,这也将改变pwCF的需求以及CF中心内外医疗保健专业人员(HCPs)的角色和使命。我们将开展一项名为“HORIZON”的全国性研究项目,以支持未来几年CF护理组织的变化。它在2022年得到了法国卫生部的财政支持。我们的主要目标是设计一种新的护理模式,在这个由于HEMT而迅速而深刻变化的时代,响应pwCF和HCPs的新需求和使命。本研究计划基于干预映射法,我们将进行前四个步骤来设计和规划实施一种新的护理模式。该项目将涉及CF护理网络的所有利益相关者,包括CF护理中心和外部的HCPs, pwCF,他们的家人,患者组织和CF专家。它将结合定量和定性研究方法,并依赖于“行动研究”方法。预测和支持法国CF护理的重组需要一个强有力的研究计划,以找到满足所有关键利益相关者期望的最佳模式。
{"title":"Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy","authors":"Julie Haesebaert ,&nbsp;Quitterie Reynaud ,&nbsp;Isabelle Durieu ,&nbsp;Stephanie Poupon-Bourdy ,&nbsp;Thierry Nouvel ,&nbsp;Philippe Reix ,&nbsp;the Horizon CF center’s investigators","doi":"10.1016/j.arcped.2025.08.001","DOIUrl":"10.1016/j.arcped.2025.08.001","url":null,"abstract":"<div><div>Highly effective modulator therapy (HEMT) is available to a broader range of people with cystic fibrosis (pwCF). It has significantly improved short-term clinical outcomes and has the potential to alter the natural history of this fatal genetic disease. If long-term follow-up observational data is required to ensure clinical benefits, it is obvious that it will also change the needs of pwCF and the roles and missions of healthcare professionals (HCPs) in CF centers and beyond. We will conduct a nationwide research program called 'HORIZON' to support the changes in the organization of CF care in the coming years. It has received the financial support of the French Ministry of Health in 2022. Our primary objective is to design a new model of care that respond to the new needs and missions of pwCF and HCPs in this era of rapid and profound changes due to HEMT. This research program is based on the intervention mapping method, in which we will conduct the first four steps to design and plan the implementation of a new model of care. The program will involve all stakeholders of the CF care network, including HCPs from CF care centers and outside, pwCF, their families, patient organizations, and experts in CF. It will combine quantitative and qualitative research approaches and rely on an 'action research' method. Anticipating and supporting the reorganization of CF care in France requires a robust research program to find the best model that meets the expectations of all key stakeholders.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 532-537"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NT-proBNP plasma levels as early predictor of ventilatory support in bronchiolitis: A prospective analysis NT-proBNP血浆水平作为毛细支气管炎通气支持的早期预测因子:一项前瞻性分析。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.06.006
Zayani Seyfeddine , Thabet Farah , Daya Abir , Benabdallah Imen , Mkaouer Wejdenne , Chouchane Chokri , Neffati Fadoua , Chouchane Slaheddine

Objective

To evaluate the role of serum NT-proBNP (N-Terminal Pro Brain Natriuretic Peptide) levels as an early predictor of ventilatory support in infants hospitalized with bronchiolitis.

Design

A single-center, prospective, observational study.

Setting

Pediatric department of a tertiary university-affiliated hospital in Tunisia.

Patients

Eighty infants under one year of age, admitted with bronchiolitis between December 2023 and February 2024, were included. Infants with comorbidities such as congenital heart disease or immunosuppression were excluded.

Interventions

NT-proBNP levels were measured within 2 h of admission. Patients were managed following standard protocols, and the need for ventilatory support was documented.

Main outcome measures

The association of elevated NT-proBNP levels (>1585 pg/mL) with the requirement for ventilatory support, as well as the predictive accuracy of NT-proBNP compared to the Wang score.

Results

Of the 80 infants, 33.8 % had elevated NT-proBNP levels, and 18.8 % required ventilatory support. Median NT-proBNP levels were significantly higher in the ventilatory support group (2185 pg/mL) compared to those managed with room air or simple oxygen therapy (634 pg/mL). NT-proBNP demonstrated superior predictive accuracy (AUC 0.869) compared to the Wang score (AUC 0.701). A threshold of 1585 pg/mL yielded 73.3 % sensitivity and 87.7 % specificity. NT-proBNP elevation was independently associated with the need for ventilatory support (OR 17.1; 95 % CI 4.46–65.6).

Conclusions

NT-proBNP levels provide valuable prognostic insights into bronchiolitis severity and outperform clinical severity scores like the Wang score in predicting ventilatory support needs. Integration of NT-proBNP measurement into clinical practice may enhance risk stratification and improve management of high-risk infants.
目的:评价血清NT-proBNP (n -末端前脑利钠肽)水平作为毛细支气管炎住院婴儿通气支持的早期预测指标的作用。设计:单中心、前瞻性、观察性研究。地点:突尼斯一所大学附属医院的儿科。患者:包括80名一岁以下的婴儿,在2023年12月至2024年2月期间因毛细支气管炎入院。排除有先天性心脏病或免疫抑制等合并症的婴儿。干预措施:入院后2小时内测量NT-proBNP水平。患者按照标准方案进行管理,并记录了通气支持的需要。主要结局指标:NT-proBNP水平升高(>1585 pg/mL)与通气支持需求的关系,以及NT-proBNP与Wang评分的预测准确性。结果:在80名婴儿中,33.8%的婴儿NT-proBNP水平升高,18.8%的婴儿需要呼吸支持。呼吸支持组NT-proBNP水平中位数(2185 pg/mL)明显高于室内空气或简单氧疗组(634 pg/mL)。NT-proBNP的预测准确度(AUC 0.869)优于Wang评分(AUC 0.701)。阈值为1585 pg/mL,敏感性为73.3%,特异性为87.7%。NT-proBNP升高与通气支持需求独立相关(OR 17.1; 95% CI 4.46-65.6)。结论:NT-proBNP水平为细支气管炎严重程度提供了有价值的预后见解,并且在预测呼吸支持需求方面优于临床严重程度评分(如Wang评分)。将NT-proBNP测量整合到临床实践中可以加强风险分层,改善高危婴儿的管理。
{"title":"NT-proBNP plasma levels as early predictor of ventilatory support in bronchiolitis: A prospective analysis","authors":"Zayani Seyfeddine ,&nbsp;Thabet Farah ,&nbsp;Daya Abir ,&nbsp;Benabdallah Imen ,&nbsp;Mkaouer Wejdenne ,&nbsp;Chouchane Chokri ,&nbsp;Neffati Fadoua ,&nbsp;Chouchane Slaheddine","doi":"10.1016/j.arcped.2025.06.006","DOIUrl":"10.1016/j.arcped.2025.06.006","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the role of serum NT-proBNP (N-Terminal Pro Brain Natriuretic Peptide) levels as an early predictor of ventilatory support in infants hospitalized with bronchiolitis.</div></div><div><h3>Design</h3><div>A single-center, prospective, observational study.</div></div><div><h3>Setting</h3><div>Pediatric department of a tertiary university-affiliated hospital in Tunisia.</div></div><div><h3>Patients</h3><div>Eighty infants under one year of age, admitted with bronchiolitis between December 2023 and February 2024, were included. Infants with comorbidities such as congenital heart disease or immunosuppression were excluded.</div></div><div><h3>Interventions</h3><div>NT-proBNP levels were measured within 2 h of admission. Patients were managed following standard protocols, and the need for ventilatory support was documented.</div></div><div><h3>Main outcome measures</h3><div>The association of elevated NT-proBNP levels (&gt;1585 pg/mL) with the requirement for ventilatory support, as well as the predictive accuracy of NT-proBNP compared to the Wang score.</div></div><div><h3>Results</h3><div>Of the 80 infants, 33.8 % had elevated NT-proBNP levels, and 18.8 % required ventilatory support. Median NT-proBNP levels were significantly higher in the ventilatory support group (2185 pg/mL) compared to those managed with room air or simple oxygen therapy (634 pg/mL). NT-proBNP demonstrated superior predictive accuracy (AUC 0.869) compared to the Wang score (AUC 0.701). A threshold of 1585 pg/mL yielded 73.3 % sensitivity and 87.7 % specificity. NT-proBNP elevation was independently associated with the need for ventilatory support (OR 17.1; 95 % CI 4.46–65.6).</div></div><div><h3>Conclusions</h3><div>NT-proBNP levels provide valuable prognostic insights into bronchiolitis severity and outperform clinical severity scores like the Wang score in predicting ventilatory support needs. Integration of NT-proBNP measurement into clinical practice may enhance risk stratification and improve management of high-risk infants.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 580-584"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NEOSKID study: Four years of experience in newborn screening for severe combined immunodeficiencies in the Pays de la Loire region of France NEOSKID研究:法国卢瓦尔河地区新生儿严重联合免疫缺陷筛查的四年经验
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.07.004
Marie Rimbert , Marie Audrain , Alexandra Léger , Charline Miot , Aurélie Fantou , Caroline Hémont , Lea Lemoine , Caroline Poli , Isabelle Pellier , Aurore Catteau , Gervaise Hubert , Jérôme Martin , Audrey Grain , Caroline Thomas
In this article, we report the results of four years (2019–2023) of newborn blood spot screening for severe lymphopenia using TREC (T-cell receptor excision circle) quantification in the Pays de la Loire region in France. Our main objective was to analyze underlying causes of T-cell lymphopenia revealed by positive testing. During the study period, 156,892 newborns were screened and ten were identified with T-cell lymphopenia (1/13,260 births), of whom three were diagnosed with severe combined immunodeficiencies (SCID: 1/40,000 births). Our results confirm data from international reports and our previous nationwide study (DEPISTREC; 2015 to 2017). We conclude that routine newborn screening for T-cell lymphopenia is operational to detect and swiftly treat infants with SCID.
在本文中,我们报告了在法国卢瓦尔省(Pays de la Loire)使用TREC (t细胞受体切除环)定量筛查新生儿重度淋巴细胞减少症的四年(2019-2023)结果。我们的主要目的是分析阳性检测显示的t细胞淋巴细胞减少的潜在原因。在研究期间,对156,892名新生儿进行了筛查,其中10名被发现患有t细胞淋巴细胞减少症(1/13,260名新生儿),其中3名被诊断为严重联合免疫缺陷(SCID: 1/40,000名新生儿)。我们的研究结果证实了国际报告和我们之前的全国研究(DEPISTREC; 2015年至2017年)的数据。我们的结论是,常规的新生儿t细胞淋巴细胞减少筛查对于发现和快速治疗SCID婴儿是可行的。
{"title":"NEOSKID study: Four years of experience in newborn screening for severe combined immunodeficiencies in the Pays de la Loire region of France","authors":"Marie Rimbert ,&nbsp;Marie Audrain ,&nbsp;Alexandra Léger ,&nbsp;Charline Miot ,&nbsp;Aurélie Fantou ,&nbsp;Caroline Hémont ,&nbsp;Lea Lemoine ,&nbsp;Caroline Poli ,&nbsp;Isabelle Pellier ,&nbsp;Aurore Catteau ,&nbsp;Gervaise Hubert ,&nbsp;Jérôme Martin ,&nbsp;Audrey Grain ,&nbsp;Caroline Thomas","doi":"10.1016/j.arcped.2025.07.004","DOIUrl":"10.1016/j.arcped.2025.07.004","url":null,"abstract":"<div><div>In this article, we report the results of four years (2019–2023) of newborn blood spot screening for severe lymphopenia using TREC (T-cell receptor excision circle) quantification in the Pays de la Loire region in France. Our main objective was to analyze underlying causes of T-cell lymphopenia revealed by positive testing. During the study period, 156,892 newborns were screened and ten were identified with T-cell lymphopenia (1/13,260 births), of whom three were diagnosed with severe combined immunodeficiencies (SCID: 1/40,000 births). Our results confirm data from international reports and our previous nationwide study (DEPISTREC; 2015 to 2017). We conclude that routine newborn screening for T-cell lymphopenia is operational to detect and swiftly treat infants with SCID.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 570-574"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145454226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neonatal screening: Development and evaluation of a video as an informational resource for parents. Prospective single-center study in a level III maternity hospital 新生儿筛查:开发和评估视频作为父母的信息资源。某三级妇产医院前瞻性单中心研究。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.08.006
Sophie Briols, Karine Mention Mulliez, Thameur Rakza

Background

Neonatal screening, including biological assessments and hearing impairment evaluations, is offered to all newborns in France. It is essential to provide parents with adequate information to ensure informed consent; however, current efforts remain insufficient. This study aimed to develop and evaluate an informational video for parents regarding these screenings.

Materials and Methods

The video, a two-minute animated presentation accessible on the in-room televisions, was developed by a multidisciplinary working group and assessed through a prospective survey, which involved distributing questionnaires to parents during their stay at the Jeanne de Flandre maternity ward of Lille University Hospital between October 2022 and October 2023.

Results

A total of 417 parents participated. Their feedback on the video was positive, with 89.2 % feeling adequately informed about the screenings their newborns would undergo. Parents rated the format as appropriate (5.0 [4.0; 5.0] on a Likert scale of 1 to 5), the video as easy to understand (5.0 [4.0; 5.0]), and reassuring (4.0 [4.0; 5.0]).

Conclusion

Informational videos are an effective and well-received method for educating parents about neonatal screening.
背景:新生儿筛查,包括生物学评估和听力损伤评估,在法国提供给所有新生儿。必须向父母提供充分的信息,以确保知情同意;然而,目前的努力仍然不够。本研究旨在为家长制作和评估有关这些筛查的信息视频。材料和方法:该视频是一个两分钟的动画演示,可在室内电视上观看,由一个多学科工作组开发,并通过一项前瞻性调查进行评估,该调查包括向2022年10月至2023年10月期间在里尔大学医院让娜·德·弗兰德产科病房住院的父母分发问卷。结果:共有417名家长参与。他们对视频的反馈是积极的,89.2%的人认为他们对新生儿将接受的筛查有充分的了解。家长对视频格式的评价为“合适”(李克特评分为1到5,评分为5.0[4.0;5.0]),“易于理解”(5.0[4.0;5.0]),“令人放心”(4.0[4.0;5.0])。结论:信息视频是一种有效且受欢迎的教育新生儿筛查父母的方法。
{"title":"Neonatal screening: Development and evaluation of a video as an informational resource for parents. Prospective single-center study in a level III maternity hospital","authors":"Sophie Briols,&nbsp;Karine Mention Mulliez,&nbsp;Thameur Rakza","doi":"10.1016/j.arcped.2025.08.006","DOIUrl":"10.1016/j.arcped.2025.08.006","url":null,"abstract":"<div><h3>Background</h3><div>Neonatal screening, including biological assessments and hearing impairment evaluations, is offered to all newborns in France. It is essential to provide parents with adequate information to ensure informed consent; however, current efforts remain insufficient. This study aimed to develop and evaluate an informational video for parents regarding these screenings.</div></div><div><h3>Materials and Methods</h3><div>The video, a two-minute animated presentation accessible on the in-room televisions, was developed by a multidisciplinary working group and assessed through a prospective survey, which involved distributing questionnaires to parents during their stay at the Jeanne de Flandre maternity ward of Lille University Hospital between October 2022 and October 2023.</div></div><div><h3>Results</h3><div>A total of 417 parents participated. Their feedback on the video was positive, with 89.2 % feeling adequately informed about the screenings their newborns would undergo. Parents rated the format as appropriate (5.0 [4.0; 5.0] on a Likert scale of 1 to 5), the video as easy to understand (5.0 [4.0; 5.0]), and reassuring (4.0 [4.0; 5.0]).</div></div><div><h3>Conclusion</h3><div>Informational videos are an effective and well-received method for educating parents about neonatal screening.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 564-569"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How lived experience can be used to find the causes of errors in pediatric oral liquid dosage forms 如何使用生活经验来查找小儿口服液剂型错误的原因。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.08.005
Anaëlle Dollo , Jean-Philippe Rivière , Sonia Prot-Labarthe

Background

Oral liquid dosage forms (OLDFs) are the preferred choice for pediatric patients but often result in dosing errors by parents and caregivers.

Objectives

This study aimed to investigate the causes of dosing errors in the reconstitution and preparation of OLDFs.

Methods and Setting

A prospective observational qualitative study was conducted from October to November 2022. Participants were approached and recruited face-to-face by the research team in a university building (classrooms, personal offices, etc.) based on the following criteria: being 18 or older and fluent in French. They were asked to prepare a dose of either amoxicillin (Clamoxyl® GSK®, spoon) or amoxicillin-clavulanic acid (Sandoz®, dose-weight pipette) based on a prescription. After completing the task, participants underwent a micro-phenomenological interview conducted by a trained researcher. Data were analyzed using the Valenzuela Moguillansky and Vásquez-Rosati procedure, and errors were classified according to Reason’s taxonomy.

Results

Seventeen of the eighteen participants were included in the analysis. Fourteen errors were identified, primarily related to the spoon, the patient information leaflets(PIL) and the secondary packaging. The main causes included unclear and poorly visible dosing markings on the spoon, unclear water level markings on the medication bottles, and confusing PILs. Most errors were classified as Rule-Based Mistakes according to Reason’s taxonomy.

Conclusion

This study contributed to the understanding of how the occurrence of errors is multifactorial: there are not only visible errors, but also numerous misunderstandings that may or may not lead to errors. Lived experience proved invaluable in elucidating the cognitive and behavioral factors contributing to these errors and Reason’s taxonomy of errors emerged as useful and applicable in the context of medication administration.
背景:口服液体剂型(oldf)是儿科患者的首选,但往往导致家长和护理人员的剂量错误。目的:本研究旨在探讨oldf重组和制备中剂量误差的原因。方法与背景:于2022年10 - 11月进行前瞻性观察性定性研究。研究小组在大学大楼(教室、个人办公室等)面对面地接触和招募参与者,根据以下标准:年满18岁,法语流利。他们被要求根据处方准备一剂阿莫西林(Clamoxyl®GSK®,勺子)或阿莫西林-克拉维酸(Sandoz®,剂量-重量移液器)。完成任务后,参与者接受了由训练有素的研究人员进行的微观现象学访谈。使用Valenzuela Moguillansky和Vásquez-Rosati程序分析数据,并根据Reason的分类法对错误进行分类。结果:18名参与者中有17人被纳入分析。发现14个错误,主要与勺子,患者信息传单(PIL)和二次包装有关。主要原因包括勺子上的剂量标记不清楚或不太明显,药瓶上的水位标记不清楚,以及药丸混淆。根据Reason的分类法,大多数错误被归类为基于规则的错误。结论:本研究有助于理解错误的发生是多因素的:不仅有可见的错误,还有许多可能导致或不导致错误的误解。生活经验在阐明导致这些错误的认知和行为因素方面被证明是无价的,而Reason对错误的分类在药物管理的背景下变得有用和适用。
{"title":"How lived experience can be used to find the causes of errors in pediatric oral liquid dosage forms","authors":"Anaëlle Dollo ,&nbsp;Jean-Philippe Rivière ,&nbsp;Sonia Prot-Labarthe","doi":"10.1016/j.arcped.2025.08.005","DOIUrl":"10.1016/j.arcped.2025.08.005","url":null,"abstract":"<div><h3>Background</h3><div>Oral liquid dosage forms (OLDFs) are the preferred choice for pediatric patients but often result in dosing errors by parents and caregivers.</div></div><div><h3>Objectives</h3><div>This study aimed to investigate the causes of dosing errors in the reconstitution and preparation of OLDFs.</div></div><div><h3>Methods and Setting</h3><div>A prospective observational qualitative study was conducted from October to November 2022. Participants were approached and recruited face-to-face by the research team in a university building (classrooms, personal offices, etc.) based on the following criteria: being 18 or older and fluent in French. They were asked to prepare a dose of either amoxicillin (Clamoxyl® GSK®, spoon) or amoxicillin-clavulanic acid (Sandoz®, dose-weight pipette) based on a prescription. After completing the task, participants underwent a micro-phenomenological interview conducted by a trained researcher. Data were analyzed using the Valenzuela Moguillansky and Vásquez-Rosati procedure, and errors were classified according to Reason’s taxonomy.</div></div><div><h3>Results</h3><div>Seventeen of the eighteen participants were included in the analysis. Fourteen errors were identified, primarily related to the spoon, the patient information leaflets(PIL) and the secondary packaging. The main causes included unclear and poorly visible dosing markings on the spoon, unclear water level markings on the medication bottles, and confusing PILs. Most errors were classified as Rule-Based Mistakes according to Reason’s taxonomy.</div></div><div><h3>Conclusion</h3><div>This study contributed to the understanding of how the occurrence of errors is multifactorial: there are not only visible errors, but also numerous misunderstandings that may or may not lead to errors. Lived experience proved invaluable in elucidating the cognitive and behavioral factors contributing to these errors and Reason’s taxonomy of errors emerged as useful and applicable in the context of medication administration.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 585-591"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial Leigh syndrome: the state of the art 线粒体利氏综合征:最新进展。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.arcped.2025.04.007
Gauthier Toutain , Célia Hoebeke , Marguerite Gastaldi , Mathieu Milh , Brigitte Chabrol

Background

Leigh syndrome or subacute necrotizing encephalomyelopathy was first recognized as a neuropathological entity in 1951. It is a progressive neurological disease characterized by neuroradiological lesions, particularly in the brainstem and basal ganglia. Leigh's syndrome is a pan-ethnic disorder with onset usually in infancy or early childhood. Over the last six decades, this complex neurodegenerative disorder has been shown to comprise >100 separate monogenic disorders associated with enormous clinical and biochemical heterogeneity. This article reviews clinical, radiological, biochemical and genetic aspects of the disorder.

Objectives

: this overview provides a better understanding of this rare mitochondrial disease by identifying its clinical, radiological and genetic manifestations in order to improve early diagnosis, patient follow-up and genetic counseling.

Methodology

systematic literature review

Results

Leigh syndromes present with childhood developmental regression, a loss of previously achieved developmental milestones. Numerous non-neurological manifestations of Leigh syndrome have been reported, many of which are related to the underlying genetic defects. These include cardiomyopathy, renal tubulopathy, gastrointestinal and endocrine dysfunction, and liver disease. Known genetic causes, including defects in 16 mitochondrial DNA (mtDNA) genes and nearly 100 nuclear genes, are categorized into disorders of subunits and assembly factors of the five oxidative phosphorylation enzymes, disorders of pyruvate metabolism and vitamin and cofactor transport and metabolism, disorders of mtDNA maintenance, and defects in mitochondrial gene expression, protein quality control, lipid remodeling, dynamics and toxicity. An approach to diagnosis is presented, together with known treatable causes and an overview of current supportive management options and emerging therapies on the horizon

Conclusion

Management of mitochondrial diseases must be multidisciplinary, and in collaboration with a center of reference (CRMR) or a center of competence (CCMR) with expertise in mitochondrial diseases.
背景:Leigh综合征或亚急性坏死性脑脊髓病于1951年首次被认为是一种神经病理实体。它是一种进行性神经系统疾病,以神经影像学病变为特征,特别是在脑干和基底神经节。利氏综合征是一种泛民族疾病,通常在婴儿期或幼儿期发病。在过去的60年里,这种复杂的神经退行性疾病已被证明包括100多种独立的单基因疾病,这些疾病与巨大的临床和生化异质性有关。本文综述了该疾病的临床、放射学、生化和遗传学方面的情况。目的:本综述通过确定其临床、放射学和遗传学表现,更好地了解这种罕见的线粒体疾病,以改善早期诊断、患者随访和遗传咨询。方法:系统文献综述结果:Leigh综合征表现为儿童发育倒退,丧失了先前达到的发育里程碑。Leigh综合征的许多非神经系统表现已被报道,其中许多与潜在的遗传缺陷有关。这些疾病包括心肌病、肾小管病、胃肠道和内分泌功能障碍以及肝脏疾病。已知的遗传原因包括16个线粒体DNA (mtDNA)基因和近100个核基因的缺陷,可分为5种氧化磷酸化酶亚基和组装因子障碍、丙酮酸代谢和维生素及辅助因子转运代谢障碍、mtDNA维持障碍、线粒体基因表达缺陷、蛋白质质量控制缺陷、脂质重塑缺陷、动力学缺陷和毒性缺陷。本文介绍了一种诊断方法,以及已知的可治疗原因和当前支持性管理选择的概述以及即将出现的新疗法。结论:线粒体疾病的管理必须是多学科的,并与具有线粒体疾病专业知识的参考中心(CRMR)或能力中心(CCMR)合作。
{"title":"Mitochondrial Leigh syndrome: the state of the art","authors":"Gauthier Toutain ,&nbsp;Célia Hoebeke ,&nbsp;Marguerite Gastaldi ,&nbsp;Mathieu Milh ,&nbsp;Brigitte Chabrol","doi":"10.1016/j.arcped.2025.04.007","DOIUrl":"10.1016/j.arcped.2025.04.007","url":null,"abstract":"<div><h3>Background</h3><div>Leigh syndrome or subacute necrotizing encephalomyelopathy was first recognized as a neuropathological entity in 1951. It is a progressive neurological disease characterized by neuroradiological lesions, particularly in the brainstem and basal ganglia. Leigh's syndrome is a pan-ethnic disorder with onset usually in infancy or early childhood. Over the last six decades, this complex neurodegenerative disorder has been shown to comprise &gt;100 separate monogenic disorders associated with enormous clinical and biochemical heterogeneity. This article reviews clinical, radiological, biochemical and genetic aspects of the disorder.</div></div><div><h3>Objectives</h3><div><em>:</em> this overview provides a better understanding of this rare mitochondrial disease by identifying its clinical, radiological and genetic manifestations in order to improve early diagnosis, patient follow-up and genetic counseling.</div></div><div><h3>Methodology</h3><div>systematic literature review</div></div><div><h3>Results</h3><div>Leigh syndromes present with childhood developmental regression, a loss of previously achieved developmental milestones. Numerous non-neurological manifestations of Leigh syndrome have been reported, many of which are related to the underlying genetic defects. These include cardiomyopathy, renal tubulopathy, gastrointestinal and endocrine dysfunction, and liver disease. Known genetic causes, including defects in 16 mitochondrial DNA (mtDNA) genes and nearly 100 nuclear genes, are categorized into disorders of subunits and assembly factors of the five oxidative phosphorylation enzymes, disorders of pyruvate metabolism and vitamin and cofactor transport and metabolism, disorders of mtDNA maintenance, and defects in mitochondrial gene expression, protein quality control, lipid remodeling, dynamics and toxicity. An approach to diagnosis is presented, together with known treatable causes and an overview of current supportive management options and emerging therapies on the horizon</div></div><div><h3>Conclusion</h3><div>Management of mitochondrial diseases must be multidisciplinary, and in collaboration with a center of reference (CRMR) or a center of competence (CCMR) with expertise in mitochondrial diseases.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 8","pages":"Pages 509-516"},"PeriodicalIF":1.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145454287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of prognostic factors for high-flow nasal cannula therapy failure in infants with bronchiolitis: a prospective study 婴儿毛细支气管炎高流量鼻插管治疗失败的预后因素评估:一项前瞻性研究。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-10-01 DOI: 10.1016/j.arcped.2025.06.002
Seyfeddine Zayani , Farah Thabet , Amal Marzouki , Abir Daya , Manel Benfredj , Salma Mhalla , Chokri Chouchane , Slaheddine Chouchane

Objective

This study aims to identify factors associated with High-flow nasal cannula (HFNC) therapy failure in infants with moderate to severe bronchiolitis to personalize management and optimize outcomes.

Methods

A prospective cohort study was conducted from September 2021 to March 2023 in a pediatric intensive care unit. Infants aged 0–12 months with bronchiolitis requiring HFNC were included, excluding those with prior ventilation, tracheostomy, uncorrected cyanotic congenital heart disease, or chronic respiratory/neuromuscular conditions. Clinical and biological characteristics were evaluated at HFNC initiation and after 2 hours. Logistic regression was used to identify predictors of failure.

Results

Of 154 patients, 54 (35.1 %) experienced HFNC failure. Univariate analysis showed significant differences in age and weight at admission between responders and non-responders. Multivariate analysis identified weight below the 10th percentile, FiO2 ≥ 42.5 %, and Wang score ≥ 10 at initiation as predictors of failure. Persistence of tachycardia, tachypnea, hypercapnia, and FiO2 ≥ 48.5 % after 2 hours were also significant predictors. Common causes of failure were increased respiratory effort (64.8 %) and severe apnea (18.5 %).

Conclusions

Predictors of HFNC failure include low weight, high initial FiO2, and severe clinical scores, as well as persistent clinical instability during early therapy, aiding clinical decision-making.
目的:本研究旨在确定中重度毛细支气管炎婴儿高流量鼻插管(HFNC)治疗失败的相关因素,以实现个性化治疗和优化结果。方法:一项前瞻性队列研究于2021年9月至2023年3月在儿科重症监护室进行。0-12个月患有毛细支气管炎需要HFNC的婴儿被纳入研究,不包括那些先前有通气、气管切开术、未纠正的紫绀型先天性心脏病或慢性呼吸/神经肌肉疾病的婴儿。在HFNC开始时和2小时后评估临床和生物学特征。使用逻辑回归来确定失败的预测因素。结果:154例患者中,54例(35.1%)发生HFNC衰竭。单因素分析显示,应答者和无应答者入院时的年龄和体重有显著差异。多因素分析确定体重低于第10百分位,FiO2≥42.5%,开始时Wang评分≥10是失败的预测因素。持续的心动过速、呼吸急促、高碳酸血症和2小时后FiO2≥48.5%也是重要的预测因素。失败的常见原因是呼吸力增加(64.8%)和严重呼吸暂停(18.5%)。结论:HFNC失败的预测因素包括低体重、高初始FiO2、重度临床评分以及治疗早期持续的临床不稳定,有助于临床决策。
{"title":"Evaluation of prognostic factors for high-flow nasal cannula therapy failure in infants with bronchiolitis: a prospective study","authors":"Seyfeddine Zayani ,&nbsp;Farah Thabet ,&nbsp;Amal Marzouki ,&nbsp;Abir Daya ,&nbsp;Manel Benfredj ,&nbsp;Salma Mhalla ,&nbsp;Chokri Chouchane ,&nbsp;Slaheddine Chouchane","doi":"10.1016/j.arcped.2025.06.002","DOIUrl":"10.1016/j.arcped.2025.06.002","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to identify factors associated with High-flow nasal cannula (HFNC) therapy failure in infants with moderate to severe bronchiolitis to personalize management and optimize outcomes.</div></div><div><h3>Methods</h3><div>A prospective cohort study was conducted from September 2021 to March 2023 in a pediatric intensive care unit. Infants aged 0–12 months with bronchiolitis requiring HFNC were included, excluding those with prior ventilation, tracheostomy, uncorrected cyanotic congenital heart disease, or chronic respiratory/neuromuscular conditions. Clinical and biological characteristics were evaluated at HFNC initiation and after 2 hours. Logistic regression was used to identify predictors of failure.</div></div><div><h3>Results</h3><div>Of 154 patients, 54 (35.1 %) experienced HFNC failure. Univariate analysis showed significant differences in age and weight at admission between responders and non-responders. Multivariate analysis identified weight below the 10th percentile, FiO2 ≥ 42.5 %, and Wang score ≥ 10 at initiation as predictors of failure. Persistence of tachycardia, tachypnea, hypercapnia, and FiO2 ≥ 48.5 % after 2 hours were also significant predictors. Common causes of failure were increased respiratory effort (64.8 %) and severe apnea (18.5 %).</div></div><div><h3>Conclusions</h3><div>Predictors of HFNC failure include low weight, high initial FiO2, and severe clinical scores, as well as persistent clinical instability during early therapy, aiding clinical decision-making.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 7","pages":"Pages 456-462"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological disorders in pediatric emergency department: From consultation to follow-up of first epileptic seizures 儿科急诊科的神经系统疾病:从首次癫痫发作的会诊到随访。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2025-10-01 DOI: 10.1016/j.arcped.2025.05.014
Gaëlle Quentin-Romand , Philippe Eckart , Nathalie Bach , Claire Dupont , Anne-Sophie Diependaële

Background

Neurological disorders are a common reason for consultations in pediatric emergency rooms. The aims of this study were 1) to evaluate the role of neurological symptoms in consultations in pediatric emergency departments at a French hospital, and 2) to assess the management of patients presenting with a first seizure in line with the 2020 recommendations of the French National Authority for Health (Haute Autorité de Santé - HAS).

Method

This single-center retrospective observational study was carried out over a period of 16 months, from January 2021 to April 2022. Children referred for neurological symptoms were identified through the ICD10 coding. Demographic data, past medical history for neurological disorder, circumstances of arrival at the emergency room, the occurrence of advice by a child neurologist at the emergency room, and the need for hospitalization were extracted from the files. Statistical analyses were performed in the subgroups of patients consulting for seizures and for headaches. The observance of the HAS guidelines after a first unprovoked seizure was analyzed in looking for EKG and appropriate blood work-up occurrences, and time delays for EEG, MRI, and pediatric neurology consultation.

Results

734 patients presented for neurological symptoms (2.2 % of emergency consultations). Headaches (n = 282) and seizures (n = 368) represent the most frequent reasons for visits (88.5 %). Of all seizures, a first unprovoked seizure affected 45 patients (12.2 %). Considering HAS recommendations for first seizures, only 3 patients (6.7 %) had a consultation with a pediatric neurologist within 15 days, and 9 patients (20 %) underwent a brain MRI within the first month.

Discussion

Our results confirm the high frequency of consultations for neuropediatric symptoms in French emergency departments, with seizures and headaches being the most common. However, they highlight challenges in obtaining specialist neuropediatric consultations and implementing national recommendations for the management of patients with a first unprovoked seizure.

Conclusion

Based on these results, establishing specialized neurological care networks would enhance patient management and ensure better implementation of HAS recommendations.
背景:神经系统疾病是儿科急诊室就诊的常见原因。本研究的目的是:1)评估神经症状在法国一家医院儿科急诊科会诊中的作用;2)根据法国国家卫生管理局(Haute autorit de sant - HAS) 2020年的建议,评估首次癫痫发作患者的管理。方法:该单中心回顾性观察研究于2021年1月至2022年4月进行,为期16个月。通过ICD10编码确定因神经系统症状转诊的儿童。从档案中提取了人口统计数据、既往神经系统疾病病史、到达急诊室的情况、在急诊室接受儿童神经科医生咨询的情况以及住院的必要性。对癫痫发作和头痛患者的亚组进行统计分析。分析首次非诱发性癫痫发作后对HAS指南的遵守情况,寻找心电图和适当的血液检查,以及脑电图、MRI和儿科神经病学会诊的时间延迟。结果:734例患者出现神经系统症状(占急诊问诊的2.2%)。头痛(n = 282)和癫痫(n = 368)是最常见的就诊原因(88.5%)。在所有癫痫发作中,45例患者(12.2%)首次无诱发性癫痫发作。考虑到HAS对首次发作的建议,只有3名患者(6.7%)在15天内与儿科神经科医生进行了会诊,9名患者(20%)在第一个月内接受了脑部MRI检查。讨论:我们的研究结果证实了法国急诊科对神经儿科症状的高频率咨询,其中癫痫和头痛是最常见的。然而,他们强调了在获得专家神经儿科咨询和实施国家建议管理首次无端发作患者方面的挑战。结论:基于这些结果,建立专门的神经系统护理网络将加强患者管理,确保更好地实施HAS建议。
{"title":"Neurological disorders in pediatric emergency department: From consultation to follow-up of first epileptic seizures","authors":"Gaëlle Quentin-Romand ,&nbsp;Philippe Eckart ,&nbsp;Nathalie Bach ,&nbsp;Claire Dupont ,&nbsp;Anne-Sophie Diependaële","doi":"10.1016/j.arcped.2025.05.014","DOIUrl":"10.1016/j.arcped.2025.05.014","url":null,"abstract":"<div><h3>Background</h3><div>Neurological disorders are a common reason for consultations in pediatric emergency rooms. The aims of this study were 1) to evaluate the role of neurological symptoms in consultations in pediatric emergency departments at a French hospital, and 2) to assess the management of patients presenting with a first seizure in line with the 2020 recommendations of the French National Authority for Health (Haute Autorité de Santé - HAS).</div></div><div><h3>Method</h3><div>This single-center retrospective observational study was carried out over a period of 16 months, from January 2021 to April 2022. Children referred for neurological symptoms were identified through the ICD10 coding. Demographic data, past medical history for neurological disorder, circumstances of arrival at the emergency room, the occurrence of advice by a child neurologist at the emergency room, and the need for hospitalization were extracted from the files. Statistical analyses were performed in the subgroups of patients consulting for seizures and for headaches. The observance of the HAS guidelines after a first unprovoked seizure was analyzed in looking for EKG and appropriate blood work-up occurrences, and time delays for EEG, MRI, and pediatric neurology consultation.</div></div><div><h3>Results</h3><div>734 patients presented for neurological symptoms (2.2 % of emergency consultations). Headaches (<em>n</em> = 282) and seizures (<em>n</em> = 368) represent the most frequent reasons for visits (88.5 %). Of all seizures, a first unprovoked seizure affected 45 patients (12.2 %). Considering HAS recommendations for first seizures, only 3 patients (6.7 %) had a consultation with a pediatric neurologist within 15 days, and 9 patients (20 %) underwent a brain MRI within the first month.</div></div><div><h3>Discussion</h3><div>Our results confirm the high frequency of consultations for neuropediatric symptoms in French emergency departments, with seizures and headaches being the most common. However, they highlight challenges in obtaining specialist neuropediatric consultations and implementing national recommendations for the management of patients with a first unprovoked seizure.</div></div><div><h3>Conclusion</h3><div>Based on these results, establishing specialized neurological care networks would enhance patient management and ensure better implementation of HAS recommendations.</div></div>","PeriodicalId":55477,"journal":{"name":"Archives De Pediatrie","volume":"32 7","pages":"Pages 487-491"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives De Pediatrie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1